Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on April 12, 2018. The filing addresses Item 5.02 regarding compensatory arrangements for certain officers. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation adjustments.
Material Changes
The Board of Directors approved the following compensation adjustments effective May 1, 2018:
- Lisa A. Conte (CEO and President): Annual base salary increased from $440,000 to $500,000. Received a one-time cash bonus of $30,000.
- Karen S. Wright (CFO): Annual base salary increased from $240,000 to $301,000. Received a one-time cash bonus of $30,000.
- Steven R. King (EVP and Secretary): Annual base salary increased from $280,500 to $290,317.
The bonuses for Ms. Conte and Ms. Wright were awarded in recognition of their contributions to developing strategic relationships, restructuring debt, and enhancing the Company's capital base.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items beyond the context of the compensation awards.
Key Facts for Investor Verification
- Verify the total cash outflow impact of the salary increases and one-time bonuses on the Company's upcoming cash flow.
- Confirm the status of the debt restructuring and capital base enhancement efforts cited as the rationale for the executive bonuses.
- Review the Company's most recent 10-K or 10-Q filings for current liquidity and debt levels, as this 8-K does not contain those figures.